AFP and hepatocellular carcinoma: Immediately before starting treatment for HCC, tumor markers were markedly decreased (alpha-fetoprotein, from 3098 to 361 ng/mL; des-gamma-carboxy prothrombin, from 2083 to 47 mAU/mL).